Literature DB >> 30630960

Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersen.

Benedikt Winter1, René Guenther2, Albert Christian Ludolph3, Andreas Hermann2, Markus Otto3, Claudia Diana Wurster4.   

Abstract

Entities:  

Keywords:  CSF; neuromuscular

Year:  2019        PMID： 30630960     DOI： 10.1136/jnnp-2018-320033

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  18 in total

1.  Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.

Authors:  Claudia D Wurster; Petra Steinacker; René Günther; Jan C Koch; Paul Lingor; Zeljko Uzelac; Simon Witzel; Kurt Wollinsky; Benedikt Winter; Alma Osmanovic; Olivia Schreiber-Katz; Rami Al Shweiki; Albert C Ludolph; Susanne Petri; Andreas Hermann; Markus Otto
Journal:  J Neurol       Date:  2019-09-24       Impact factor: 4.849

2.  Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1.

Authors:  Carlo Wilke; David Mengel; Ludger Schöls; Holger Hengel; Maria Rakowicz; Thomas Klockgether; Alexandra Durr; Alessandro Filla; Bela Melegh; Rebecca Schüle; Kathrin Reetz; Heike Jacobi; Matthis Synofzik
Journal:  Neurology       Date:  2022-03-09       Impact factor: 11.800

3.  Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS.

Authors:  Michael Benatar; Lanyu Zhang; Lily Wang; Volkan Granit; Jeffrey Statland; Richard Barohn; Andrea Swenson; John Ravits; Carlayne Jackson; Ted M Burns; Jaya Trivedi; Erik P Pioro; James Caress; Jonathan Katz; Jacob L McCauley; Rosa Rademakers; Andrea Malaspina; Lyle W Ostrow; Joanne Wuu
Journal:  Neurology       Date:  2020-05-08       Impact factor: 9.910

4.  Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?

Authors:  Alessandro Introna; Giammarco Milella; Eustachio D'Errico; Angela Fraddosio; Gaspare Scaglione; Maria Ucci; Maddalena Ruggieri; Isabella Laura Simone
Journal:  Muscle Nerve       Date:  2021-03-13       Impact factor: 3.217

5.  Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.

Authors:  Claudia D Wurster; René Günther; Petra Steinacker; Jens Dreyhaupt; Kurt Wollinsky; Zeljko Uzelac; Simon Witzel; Tugrul Kocak; Benedikt Winter; Jan C Koch; Paul Lingor; Susanne Petri; Albert C Ludolph; Andreas Hermann; Markus Otto
Journal:  Ther Adv Neurol Disord       Date:  2019-05-10       Impact factor: 6.570

Review 6.  An update on genetic frontotemporal dementia.

Authors:  Caroline V Greaves; Jonathan D Rohrer
Journal:  J Neurol       Date:  2019-05-22       Impact factor: 4.849

Review 7.  Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy.

Authors:  Didu S T Kariyawasam; Arlene D'Silva; Cindy Lin; Monique M Ryan; Michelle A Farrar
Journal:  Front Neurol       Date:  2019-08-19       Impact factor: 4.003

8.  Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.

Authors:  Maggie C Walter; Stephan Wenninger; Simone Thiele; Julia Stauber; Miriam Hiebeler; Eva Greckl; Kristina Stahl; Astrid Pechmann; Hanns Lochmüller; Janbernd Kirschner; Benedikt Schoser
Journal:  J Neuromuscul Dis       Date:  2019

9.  Serum creatinine is a biomarker of progressive denervation in spinal muscular atrophy.

Authors:  Christiano R R Alves; Ren Zhang; Alec J Johnstone; Reid Garner; Pann H Nwe; Jennifer J Siranosian; Kathryn J Swoboda
Journal:  Neurology       Date:  2019-12-27       Impact factor: 9.910

10.  Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice.

Authors:  Christian Barro; Jeannette Hübener-Schmid; Matthis Synofzik; Carlo Wilke; Eva Haas; Kathrin Reetz; Jennifer Faber; Hector Garcia-Moreno; Magda M Santana; Bart van de Warrenburg; Holger Hengel; Manuela Lima; Alessandro Filla; Alexandra Durr; Bela Melegh; Marcella Masciullo; Jon Infante; Paola Giunti; Manuela Neumann; Jeroen de Vries; Luis Pereira de Almeida; Maria Rakowicz; Heike Jacobi; Rebecca Schüle; Stephan A Kaeser; Jens Kuhle; Thomas Klockgether; Ludger Schöls
Journal:  EMBO Mol Med       Date:  2020-06-08       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.